2^nd World Bio Summit & Expo October 10-12, 2016 Dubai, UAE

George Perry is dean of the College of Sciences and professor of biology at The University of Texas at San Antonio Perry is recognized in the field of Alzheimemiddot;s disease research particularly for his work on oxidative stress. Perry received his bachelormiddot;s of arts degree in zoology with high honors from University of California Santa Barbara After graduation he headed to Scripps Institution of Oceanography and obtained his PhD in marine biology under David Epel in 1979 He then received a postdoctoral fellowship in the Department of Cell Biology in the laboratories of Drs Bill Brinkley and Joseph Bryan at Baylor College of Medicine where he laid the foundation for his observations of abnormalities in cell structures

Alzheimer disease Oxidative stress Parkinson disease Cytoskeleton Mitochondria Amyloidosis Neuropathology Cytochemistry.

As Executive Director of Sidra Ventures, Herlands leads commercialization initiatives and entrepreneurship to support Sidra\'s mission to become a world-class academic health center, focusing on women\'s and children\'s health. Louis Herlands innovates at the crossroads of academia, entrepreneurship, finance, and industry. Herlands brings a broad set of experience and expertise in technology commercialization, licensing, start-ups, and translational research. Herlands leverages his scientific expertise to form, finance, and lead successful biotechnology companies that are developing important new medicines in diverse therapeutic areas including diabetes, obesity, pain due to nerve damage, and cancer. The peak value of the publically traded companies he has co-founded, financed and led is in excess of $8 billion. These companies are based on patented new discoveries that have the ability to transform medicine, and help millions of patients worldwide. Herlands graduated from Yale University and received his PhD from The Rockefeller University.

Biotech and Pharmaceutical Industry

The supramolecular nanoscale assembly group is a multidisciplinary team of scientists, engineers and technical staff dedicated to understanding the underlying concepts of molecular recognition, self-assembly and self-organization processes, and utilizing this knowledge to advance the health and medical technologies, energy and environment, information and communication technologies, and nanomaterials sectors. The mission of our group is to (a) harness the properties and architecture of matter from the ground up through supramolecular synthesis, self-assembly and self-organization, (b) create new materials for application in sustainable energy generation, catalysis, nanoelectronics, and nanomedicine, (c) develop new technology platforms to address significant public health problems and meet current technological challenges, (d) train highly qualified graduate students, postdoctoral fellows and technical staff. Our group focuses specifically on the development of a variety of nanomaterials (organic nanotubes, metal nanoparticles, nanocrystalline cellulose) for applications as: (a) adaptable scaffolds for drug display/delivery, in particular for cancer, lung inflammation, and bone therapy; (b) coatings for optimal medical device integration in living systems; (c) electroactive and photoactive components for organic photovoltaics and nanoelectronics; (d) catalysts; (e) platforms for ultradetection; (f) components in composite materials. In the context of these investigations, we explore the fundamentals of self-assembly and self-organization processes, to advance the design of materials with predefined dimensions and physical properties, and explore commercialization opportunities in the nanomedical device arena.

Nanotechnology for Biomedical applications, Nanoscale materials for drug delivery, and Cell therapeutics and Regenerative medicine

Dr. Wang, MD, PhD, MPH, is Director of the Center for Genomics and a Professor in the Department of Basic Sciences, School of Medicine, Loma Linda University (LLU). He received his MD and MPH from Tongji Medical University, Wuhan, China, and his PhD from University of Washington, Seattle, WA, USA. Dr. Wang has worked for the US DOE’s Argonne National Lab, the US FDA’s National Center for Toxicological Research (NCTR) and the US DOD’s Air Force Research Laboratory (AFRL). He had held the positions as Scientific Director of the Functional Genomics Core at City of Hope National Medical Center, Associate Professor of Medicine at the David Geffen School of Medicine at UCLA and Director of the Clinical Transcriptional Genomics Core at Cedars-Sinai Medical Center before joining LLU. Dr. Wang is a recipient of several awards, including the AACR-Bristol-Myers Squibb Young Investigator Award of the American Association for Cancer Research and the first place graduate award for Research Excellence of Society of Toxicology. Dr. Wang serves as Editorial Board Members for many journals such as the World Journal of Stem Cells, the Frontiers, and the Single Cell Genomics & Proteomics. Dr. Wang is an expert on genomics and transcriptomics, with many high visibility peer-reviewed papers published in the high profile journals such as Nature Biotechnology, Nature Communications and PNAS. He was an invited speaker for many prestigious conferences such as Wellcome Trust Scientific Conference, Rat Genomics and Models 2014, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK. Dr. Wang was one of the project leaders for the MicroArray Quality Control (MAQC) and Sequencing Quality Control (SEQC) consortium.

Epigenomics and longevity/health, Alternative splicing and ncRNAs in developmental rat heart and brain, Hypoxia and epigenomic reprogramming in rat heart and brain

Born May 29, 1961 Italy, Giuseppe Mucci started off his journey studying at the University of Urbino "Carlo Bo" in the Faculty of Medicine and earned a degree in Physical Education later he specialized in psycho-motility. He has been always interested in all innovative approaches in the medical field so that in his business he could positively improve the health of humanity in respect of human physiology, avoiding chemistry and invasive surgery. He has covered important roles in introducing the most advanced medical informatics in medical nutrition therapy and body composition, as well as having transferred the innovation of the aerospace technology for the early detection of melanoma by video-dermoscopy to optical probe. After a solid introduction into the world of medicine, Giuseppe then lifted his career by founding his company in 1999, operating in the sector of equipment and biotechnology. Giuseppe Mucci has always considered knowledge as a cornerstone in the development of his company and of the surrounding world, for this reason in 2005 he launched the Bioscience Foundation (UK) dedicated to knowledge sharing, content management, T-learning and peer-to-peer learning in medical science. In the following year he established Bioscience Institute in San Marino Italy, built as a Cell Factory taking advantage of the latest technological solutions available on the market at the time. This soon became known as a centre of excellence in the field expressing the highest level of quality and transparency. He has created a unique laboratory model in the world so that everyone can verify the quality standards by connecting to the website with access to environmental parameters and webcam. After eight years of extensive research, the foundation was followed with an exclusive launch in 2013; Bioscience Clinic Middle East. The new clinic, located in Dubai HealthCare City, specializes in regenerative medicine dedicated to the Autologous Adipose Derived Stem Cells Therapies. The facility is the first and the only private structure of the industry in the Middle East.

Stem Cells

Education: MBBS., 2000, College of Medicine, University of Ibadan, Nigeria M.S., 2004, University of Hull, United Kingdom Ph.D., 2007, University of East Anglia, United Kingdom Post doc., 2007-2014, University of East Anglia/Virginia Commonwealth University/University of Florida

Cancer Biology: The overall goal of our laboratory is to elucidate the mechanisms of metastasis in solid cancers. Ongoing studies include examination of the role of circulating tumor cell biology and epigenetics in the metastasis of solid cancers. Also, our laboratory is investigating the biological mechanisms underlying the racial disparities in specific solid cancers. The cancer models we are currently focused on are hepatocellular carcinoma, pancreatic cancer, colon cancer, and prostate cancer.

Dr Godfrey Grech is Senior Lecturer at the University of Malta and currently responsible for the National Breast Cancer Research Project. He is highly recognised by the clinical sector and runs numerous projects in colabration with Mater Dei Hospital and International Institutions such as the Molecular Medicine Institute in Leeds. The main research topic aims to identify biomarkers to classify breast cancer patients into a specific therapeutic group that shall benefit from activation of phosphatases as a main therapeutic option. Dr Godfrey Grech is part of international scientific committees including the International Scientific Council of the European Group for Molecular Pathology (EMP); Global Leader at the Genomic Medicine within the National Human Genome Research Institute (NHGRI) of the U.S. National Institutes of Health (NIH); member of the Pharmacogenomics Working Group of the Global Genomic Medicine Consortium (G2MC); Leader of the Cancer Position Paper at the European Association for Predictive, Preventive & Personalised medicine (EPMA); and national contact point for the PharmacoGenetics for Every Nation Initiative (PGENI)..

Molecular Pathology, Erythropoiesis

Kelly Tan has completed her PhD in 2004 at the University of Bern and a postdoctoral study at the University of Geneva. She opened her lab in October 2014 at the Biozentrum, University of Basel where her team dissects the circuitry linked to the basal ganglia, the brain ensemble of structures responsible for coordinated movements. To achieve this, her team combines several techniques from the molecular, the cellular to the behavioral levels with pharmacological and¬¬ optogenetic tools. This wide array of techniques allows the precise identification of neurons involved in specific aspects of motor behavior both in physiology and pathology.

Neuroscience, Medical Neurosciences, Neurobiology and Brain Physiology, Neurodegeneration, Sleep, Memory and Learning, Motor Learning and Motor Control, Electrophysiology

Claire Hellio has completed her PhD in Biological Oceanography. She has been a recipient of Many national and International Grants, Awards through out her Career. She has been an Editor of various International Journals. She is been working as an Professor - researcher at University of Occidental Bretagne (Brest, France) in the Marine Environmental Sciences Laboratory.

Biofouling/surfaces colonization, antifouling solutions, natural products with biological activities (antimicrobial and cosmetics properties ; antifouling), screening program, marine biotechnology, marine biochemistry / enzymology and bioassays design.

Will be updated soon

Will be updated soon

Firdos Alam Khan, Full Professor, and Chairperson, School of Life Sciences, Manipal University Dubai, UAE received his Doctoral degree in Neuroscience from Nagpur University, India. He has 22 years of research and teaching experience in various domains of Biotechnology. He did his first Post-doctoral research from National Institute of Biological Science, Tata Institute of Fundamental Research, Bangalore, India and second Post-doctoral Fellowship from Massachusetts Institute of Technology, Cambridge, USA. His area of specialty in Biotechnology includes Stem Cell Technology, Neuropharmacology, and Neuroscience. He has been awarded two US patents for his discovery in the stem cells.

Stem Cell Technology, Neuropharmacology, Neuroscience

Amr Amin has completed his PhD at University of Illinois at Chicago, and received a post-doctoral training in the field of molecular genetics at the University of Pennsylvania School of Medicine. He started his academic career at UAE University where he serves now as a Full Professor of Cell Biology. Amr’s research focuses on ways to control cancer, particularly liver cancer. He published many research articles and reviews and serves as reviewer and as an editorial member of many specialized peer-reviewed journals. He is also a member of many specialized societies and the sole recipient of many scientific awards.

Cell & Molecular Biology, Bioinformatics, Biotechnology, Cancer Research

Dr. Khalid Al-Anazi is a consultant hematologist and head of Department of Adult Hematology and Hematopoietic Stem Cell Transplantation (HSCT) at King Fahad Specialist Hospital (KFSH) in Dammam, Saudi Arabia. He graduated from the College of Medicine, King Saud University (KSU) in Riyadh, in the year 1986. After passing his Boards in Internal Medicine, he trained in clinical hematology and HSCT at King’s College Hospital, University of London, U.K. He has 24 year experience in adult clinical hematology and HSCT at Riyadh Armed Forces Hospital then King Faisal Specialist Hospital and Research Centre (KFSH&RC) in Riyadh, King Khalid University Hospital (KKUH) in Riyadh and KFSH in Dammam Saudi Arabia. During his work at KFSH&RC in Riyadh, he looked after the first matched unrelated donor allogeneic HSCT and he contributed to the success and achievements of that institution in the years 2004 and 2005. He established the HSCT unit at KFSH in Dammam in 2010. He was selected as the best teacher in the department of internal medicine at KKUH & the College of Medicine, KSU in Riyadh in the year 2014. Also, he has 60 publications including retrospective studies, review articles, book chapters and electronic books and he reviews for 21 international medical journals in addition to being an editorial board member of 6 stem cell transplantation, hematology, cancer and infectious diseases journals.

Stem cell, Hematology

Sulaiman Al-Zuhair is a Professor of Chemical Engineering at UAE University. Prior to joining UAE University, in 2006, Prof. Al-Zuhair worked as an Assistant Professor in the School of Chemical and Environmental Engineering, at Nottingham University, Malaysia Campus. He obtained his PhD in Biochemical Engineering, from the University of Malaya in 2003, his M.Sc. degree in Chemical and Environmental Engineering from University Putra Malaysia in 1998 and his B.Sc. degree in Chemical Engineering from Jordan University of Science and Technology in 1996. Prof. Al-Zuhair is the author of a book titled: "Supercritical Fluids Technology in Lipase Catalyzed Processes". In addition, Prof. Al-Zuhair published two US Patents, 53 peer-reviewed journal papers, two book chapters, two papers in educational journals and 31 papers in conference proceedings. Majority of his research, which is funded by various funding agencies, is on the uses of enzymes in various industrial applications, specifically in biofuels production. Prof. Al-Zuhair is a member of the Editorial Boards of several international journals.

Chemical and Environmental Engineering, biofuels, enzymes,

Kinda Khalaf received her B.S. (Summa Cum Laude with Distinction) and M.S. (Honors) in Mechanical Engineering from the Ohio State University. Her Ph.D., also from OSU, is in Biomechanics/Computational Biomechanics. She has held several prestigious international academic appointments and currently serves as the associate chair of Biomedical Engineering at Khalifa University, Abu Dhabi. Dr. Khalaf is on the list of International Who’s Who of Professionals. She has multiple awards and honors reflecting academic and leadership excellence. Her research in the areas of Orthopedic and Computational Biomechanics is reflected in numerous journal and book chapter publications, lectures and conference proceedings.

Biomechanics, Computational Biomechanics, Biomaterials, Human Movement and Control

Kambadur Muralidhar is a distinguised Biologist of our country and was born at Coimbatore,Tamil Nadu.He obtained his BSc and MSc from Osmania University, Hydrabad. He Started his research work under LK Ramachandran, at Osmania in the summer of 1969.He obtained his PhD from IISc,Bangalore in 1976 working under NR Moudgal. His PhD work,demonstrating that beta subunit of Luteinizing Hormone can bind ovarian receptors fetched him the Prof KV Giri Memorial Gold medal for the best PhD thesis of the year. He was selected for the first Lecturership in the School of Life Sciences at the newly founded Central University of Hydrabad in August 1976. During 1979-81 he was a Research Associate in the Department of Cell and Molecular Biology at SUNY,Buffalo,New York,USA with OP Bahl. His Work led to the development of the most sensitive RIA for HCG,a pregnancy hormone.He also demonstrated the immuno-contraceptive vaccine potential of DS5-hCG beta subunit. He joined the University of Delhi in 1983 as Reader in Biochemistry and became a Professor in Endocrinology in 1988. He was Chairman of the Department during 2001-2004.

Embryo transfer technology, Cell and Molecular Biology

Bassem M Raafat has completed his PhD from Cairo University and Postdoctoral studies from the National Research Center, Egypt. He is the Vice Dean of Applied Medical Science College, Taif University, Saudi Arabia. He is the Head of E-Learning Unit and Scientific Research and Higher Education. He is the Coordinator of The Genetic Engineering and Biotechnology Division in NRC. He has published more than 42 papers in reputed journals and has been serving as an Editorial Board Member for more than 15 international well ranked journals.

Biophysics, Radio logical science, magnetized water